Home » Stocks » NPCE

NeuroPace, Inc. (NPCE)

NeuroPace will go public soon. The estimated IPO date is April 21, 2021.
Stock Price: $15.00 - $17.00
Current IPO price range
Market Cap 359.15M
Revenue (ttm) 41.14M
Net Income (ttm) -24.28M
Shares Out 22.45M
EPS (ttm) -1.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Hide News

There have been quite a few appealing Initial Public Offerings (IPOs) available on the market so far this year. Here are some upcoming IPOs that investors should be watching out for.

Other stocks mentioned: PATH, SKYT, SWIM, ZY
19 hours ago - Benzinga

NeuroPace, Inc. has filed to go public with an IPO on the NASDAQ.

3 weeks ago - SEC

About NPCE

NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Our novel and differentiated RNS System is the first and only commercially available, brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. By continuously monitoring the brain’s electrical activity, recognizing patient-specific abnormal electrical patterns, and responding in real time with impercep... [Read more...]

Industry
Medical Devices
IPO Date
Apr 21, 2021
CEO
Michael Favet
Employees
152
Stock Exchange
NASDAQ
Ticker Symbol
NPCE
Full Company Profile

Financial Performance

In 2020, NeuroPace's revenue was $41.14 million, an increase of 11.27% compared to the previous year's $36.97 million. Losses were -$24.28 million, -19.00% less than in 2019.

Financial Statements